Monoclonal antibody detection of plasma membrane cholesterol microdomains responsive to cholesterol trafficking

Journal of Lipid Research

Volumn 42, Issue 9, 2001, Pages 1492-1500

  Kruth, Howard S ^a   Ifrim, Ina ^a   Chang, Janet ^a   Addadi, Lia ^b   Perl Treves, Daniele ^b   Zhang, Wei Yang ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Acyl CoA:cholesterol acyltransferase; ApoA I; ApoE; Atherosclerosis; Cholesterol efflux; Cyclodextrin; HDL; Ketoconazole; Macrophages; Niemann Pick type C; Progesterone

Indexed keywords

CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE INHIBITOR;

ARTICLE; ATHEROSCLEROSIS; CELL MEMBRANE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; FIBROBLAST; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; CATTLE; CELL MEMBRANE; CHOLESTEROL; CHOLESTEROL ESTERS; ENZYME INHIBITORS; ESTERIFICATION; FETAL BLOOD; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; MEMBRANE LIPIDS; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; STEROL O-ACYLTRANSFERASE;

EID: 0035655647     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Acyl coenzyme A:cholesterol acyl transferase in macrophages utilizes a cellular pool of cholesterol oxidase-accessible cholesterol as substrate
2. Rapid intracellular transport of LDL-derived cholesterol to the plasma membrane in cultured fibroblasts
3. Intracellular cholesterol transport
4. Lipoproteins activate acyl-coenzyme A:cholesterol acyltransferase in macrophages only after cellular cholesterol pools are expanded to a critical threshold level
5. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids
6. Regulation of high density lipoprotein receptors in cultured macrophages: Role of acyl-CoA: Cholesterol acyltransferase
7. Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol effiux that occurs in the absence of added cholesterol acceptors
8. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides
9. Novel effects of the acyl-coenzyme A:cholesterol acyltransferase inhibitor 58-035 on foam cell development in primary human monocyte-derived macrophages
10. Progesterone blocks intracellular translocation of free cholesterol derived from cholesteryl ester in macrophages
11. Cytotoxic cholesterol is generated by the hydrolysis of cytoplasmic cholesteryl ester and transported to the plasma membrane
12. Cellular cholesterol efflux mediated by cyclodextrins. Demonstration of kinetic pools and mechanism of efflux
13. Monoclonal antibody recognition of cholesterol monohydrate crystal faces
14. Pattern recognition by antibodies for two-dimensional arrays of molecules
15. Army targets a potential vaccine against cholesterol [news]
16. Antibodies to cholesterol, cholesterol conjugates and liposomes: Implications for atherosclerosis and autoimmunity
17. Antibodies to cholesterol
18. Sequestration of acetylated LDL and cholesterol crystals by human monocyte-derived macrophages
19. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts
20. Type C Niemann-Pick disease. Abnormal metabolism of low density lipoprotein in homozygous and heterozygous fibroblasts
21. Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins
22. Tracking cell cholesterol with cholesterol oxidase
23. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, blocks lysosomal cholesterol trafficking in macrophages
24. Pharmacological inhibition of the intracellular transport of low-density lipoprotein-derived cholesterol in Chinese hamster ovary cells
25. Inhibition of cholesteryl ester formation in human fibroblasts by an analogue of 7-ketocholesterol and by progesterone
26. Intracellular trafficking of cholesterol monitored with a cyclodextrin
27. The intracellular transport of low density lipoprotein-derived cholesterol is defective in Niemann-Pick type C fibroblasts
28. Type C Niemann-Pick disease. Lysosomal accumulation and defective intracellular mobilization of low density lipoprotein cholesterol
29. Role of Niemann-Pick type C1 protein in intracellular trafficking of low density lipoprotein-derived cholesterol
30. Cholesterol movement in Niemann-Pick type C cells and in cells treated with amphiphiles
31. Progesterone blocks cholesterol translocation from lysosomes
32. Cholesterol movement from plasma membrane to rough endoplasmic reticulum. Inhibition by progesterone
33. The fate of cholesterol exiting lysosomes
34. Esterification of plasma membrane cholesterol and triacylglycerolrich lipoprotein secretion in CaCo-2 cells: Possible role of p-glyco-protein
35. Circulation of cholesterol between lysosomes and the plasma membrane
36. Physical effects of cholesterol on arterial smooth muscle membranes: Evidence of immiscible cholesterol domains and alterations in bilayer width during atherogenesis
37. Effect of lipidic factors on membrane cholesterol topologymode of binding of theta-toxin to cholesterol in liposomes
38. Time and distance scales of membrane domain organization
39. Recent advances in membrane cholesterol domain dynamics and intracellular cholesterol trafficking
40. The spatial distribution of cholesterol in membranes
41. Removal of cellular cholesterol by pre-beta-HDL involves plasma membrane microsolubilization
42. Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages
43. The action of human high density lipoprotein on cholesterol crystals. 1. Light-microscopic observations
44. The action of human high density lipoprotein on cholesterol crystals. 2. Biochemical observations
45. Incorporation of cholesterol into apolipoprotein A-I-dimyristoylphosphatidylcholine recombinants
46. Efflux of lipid from fibroblasts to apolipoproteins: Dependence on elevated levels of cellular unesterified cholesterol
47. Cholesterol-sphingomyelin interaction in membrane and apolipoprotein-mediated cellular cholesterol efflux
48. Plasma membrane caveolae mediate the efflux of cellular free cholesterol
49. Functions of lipid rafts in biological membranes
50. Detergent-insoluble glycosphingolipid/ cholesterol-rich membrane domains, lipid rafts and caveolae (review)
51. Membrane lipid domains distinct from cholesterol/sphingomyelinrich rafts are involved in the ABCA1-mediated lipid secretory pathway
52. Apolipoprotein binding to protruding membrane domains during removal of excess cellular cholesterol
53. Localization of unesterified cholesterol in human atherosclerotic lesions. Demonstration of filipin-positive, oil-red-O-negative particles
54. Characterization of two unique cholesterol-rich lipid particles isolated from human atherosclerotic lesions
55. Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux
56. Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes
57. Ca + + antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms. I. Characterization of cellular lipid metabolism
58. Ca + + antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms. II. Characterization of intracellular morphologic changes
59. Dual pathways for the secretion of lysosomal cholesterol into a medium from cultured macrophages
60. Enrichment of human atherosclerotic plaque with phosholipids: Its effect on the solubilization of plaque cholesterol by apoproteins of HDL